Pfizer Wins China Business Confidentiality Infringement Lawsuit
This article was originally published in PharmAsia News
Executive Summary
Pfizer and Guangzhou Welman Pharmaceutical have been embroiled in a legal battle over Viagra's Chinese trademark Weige for 10 years (PharmAsia News, Apr. 14, 2008). In 2003, Pfizer hired Shanghai AIAL Information Consulting to investigate Guangzhou Welman Pharmaceutical and Shanghai Oriental Pharmaceutical, and submitted the report to the State Administration for Industry and Commerce. However, Welman considered some content in the report to infringe on its business confidentiality and sued Pfizer for unfair competition. After the trial, Guangzhou Intermediate People's Court delivered the judgment that the content of Pfizer's investigation did not constitute unfair competition, nor violate Welman's business confidentiality. (Click here for more - Chinese Language)